177 related articles for article (PubMed ID: 15492566)
1. Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer.
Nakayama S; Takeda S; Kawase Y; Inoue S; Kaneko T; Nakao A
Ann Surg; 2004 Nov; 240(5):840-4. PubMed ID: 15492566
[TBL] [Abstract][Full Text] [Related]
2. Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.
Saif MW; Hashmi S; Bell D; Diasio RB
Expert Opin Drug Saf; 2009 Sep; 8(5):507-14. PubMed ID: 19663627
[TBL] [Abstract][Full Text] [Related]
3. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
4. Liver perfusion chemotherapy for selected patients at a high-risk of liver metastasis after resection of duodenal and ampullary cancers.
Noda T; Ohigashi H; Ishikawa O; Eguchi H; Yamada T; Sasaki Y; Yano M; Imaoka S
Ann Surg; 2007 Nov; 246(5):799-805. PubMed ID: 17968172
[TBL] [Abstract][Full Text] [Related]
5. Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone.
Tsuji T; Sawai T; Takeshita H; Nakagoe T; Hidaka S; Atsushi Nanashima ; Yamaguchi H; Yasutake T; Nagayasu T; Tagawa Y
Cancer Lett; 2004 Feb; 204(1):97-104. PubMed ID: 14744539
[TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
[TBL] [Abstract][Full Text] [Related]
7. [Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil].
Ishibashi K; Sobajima J; Ishiguro T; Ohsawa T; Okada N; Miyazaki T; Yokoyama M; Inokuma S; Ishida H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2232-5. PubMed ID: 20037380
[TBL] [Abstract][Full Text] [Related]
8. Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy.
Cancer Sci; ; . PubMed ID: 31778273
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]